AXA is committed to improving access to mental health treatments in Asia and reducing stigma, and is proud to be a partner of the Yes I Can initiative, a pioneering trial to assess the effectiveness of Virtual Reality (VR) treatment for mental wellbeing. This first-of-a-kind partnership with Oxford VR and The Chinese University of Hong Kong, is piloting ground-breaking automated immersive therapy for mental health in Asia including the Greater Bay Area.
This project is the beneficiary of a financial contribution from AXA Research Fund.
Our health and wellbeing can be impacted by many different things, and low mood and anxiety can have a particularly dramatic effect on our daily social and working lives. Despite the high prevalence of low mood and anxiety, there remains a high level of stigma surrounding mental wellbeing in Asia. Also, for those who seek help, there is a long waiting time due to the lack of resources and a trained workforce.
We are proud to be launching a study to find out whether VR treatment can improve people’s wellbeing and anxiety levels and help them to feel more comfortable in social situations. Furthermore, we are determined to create more effective, evidence-based technological solutions that are widespread, quick and easily accessible.
What is immersive therapy and virtual reality (VR)?
Where will the study take place?
What will happen during the study?
We are seeking to find out whether this VR program can improve people’s mood and anxiety levels by helping them to feel more comfortable in social situations. We will compare the outcomes of people who used the VR program to those who did not.
|General enquiry:||852-2894 4769|
|Research location:||theDesk, 5/F, 95 Queensway, Admiralty, Hong Kong|
Oxford VR is a spin out company from the University of Oxford and is a world-class clinical experts in developing psychological therapies using immersive technology.
CUHK has an outstanding reputation for academic excellence and research and will be conducting the trial itself.